100 likes | 213 Views
See full summary at: https://www.alliedmarketresearch.com/remote-patient-monitoring-market<br>Remote Patient Monitoring (RPM) Market was valued at $703 million, and is expected to reach $2,130 million by 2022, supported by a CAGR of 17%. Remote patient monitoring (RPM) is a technology used to collect medical and other health-related data from individuals at one location and electronically transmit it to a healthcare provider at another location.
E N D
Remote Patient Monitoring Market Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Introduction • RPM is an innovative care delivery model that securely transmits patients data to healthcare teams, and alerts the providers about the early signs of clinical deterioration, and thus creates opportunities for timely intervention. • It allows hospital and healthcare systems to improve and ensure compliance with post-discharge plans. This is because the doctor has access to patients vitals outside the hospital premises. They identify any potential health problems using the historical track records and time-based monitoring, and intervene before they cause any emergency.
Current and Future Market Scenario • Remote Patient Monitoring (RPM) Market was valued at $703 million in 2015. • RPM Market is expected to reach $2,130 million by 2022. • RPM Market will grow at a CAGR of 17% from 2016 to 2022. • Congestive heart failure segment is estimated to lead the market throughout the analysis period, closely followed by diabetes. • Three-fourths of the remote patient monitoring market share was captured by North America and Europe in 2015.
Factors Contributing to Market Growth • The congestive heart failure (CHF) is the highest revenue-generating segment in this market owing to the high-risk and life-threatening consequences associated with heart failure, which can be avoided using RPM technologies. In addition, the increase in geriatric population that leads to increase in incidences of age-related heart problems will further drive the market growth. • The diabetes segment would exhibit significant growth in the Asia-Pacific and LAMEA, supplemented by the increase in awareness and adoption among end users.
Region Overview • Presently, North America and Europe are the most lucrative markets supplemented by factors, such as high purchasing power leading to rapid adoption of innovative technologies, increase in prevalence and incidences of chronic diseases in these region owing to the sedentary lifestyle, and established reimbursement policies along with the improved awareness. • Asia-Pacific RPM market is projected to be fastest growing geography globally. • Saudi Arabia market for remote patient monitoring is projected to grow at a high CAGR of 21.3%. • U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.
Leading Players • Companies such as Boston Scientific Corporation, Nihon Kohden, Medtronic Inc., Johnson & Johnson, and Omron Healthcare have adopted collaboration as a strategy for the growth in the RPM market. • The key players in this industry are Aerotel Medical Systems (1988) Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, General Electric Company, Nihon Kohden Corporation, Medtornic Plc, Masimo Corporation, Abbott Laboratories, Johnson and Johnson and Omron Corporation. Other players in the RPM market include A&D Company, Limited, Aipermon GmbH & Co. KG, Jawbone, Docobo Ltd., Microlife Corporation, Schiller AG, SHL Telemedicine, and Sorin Group.
Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/remote-patient-monitoring-market Follow Us On